Pamac Laboratory & Phlebotomy Svcs is categorized under Services (Unclassified) in Arlington, TX and active since 2010.
Pamac Laboratory & Phlebotomy Svcs was established in 2010, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Charles Awe at the company’s single location by writing to 840 Greenridge Drive, Arlington, Texas TX 76017 or by phoning (817) 375-3955. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pamac Laboratory & Phlebotomy Svcs |
| Contact Person: | Charles Awe |
| Address: | 840 Greenridge Drive, Arlington, Texas 76017 |
| Phone Number: | (817) 375-3955 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Pamac Laboratory & Phlebotomy Svcs was started in 2010 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Charles Awe for inquiries that concern Pamac Laboratory & Phlebotomy Svcs by calling the company number (817) 375-3955, as your correspondence is most welcome. Additionally, the physical location of the single location of Pamac Laboratory & Phlebotomy Svcs can be found at the coordinates 32.658723,-97.119494 as well as the street address 840 Greenridge Drive in Arlington, Texas 76017.
For its online presence, you may visit Pamac Laboratory & Phlebotomy Svcs’s website at and engage with its social media outlets through on Twitter and on Facebook.